Bloomage Biotechnology Co Valuation
| 688363 Stock | 50.45 0.41 0.81% |
At this time, the firm appears to be overvalued. Bloomage Biotechnology Co shows a prevailing Real Value of USD42.64 per share. The current price of the firm is USD50.45. Our model approximates the value of Bloomage Biotechnology Co from analyzing the firm fundamentals such as Return On Equity of 0.0234, current valuation of 24.06 B, and Profit Margin of 0.03 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 3.4622 | Enterprise Value 24.1 B | Enterprise Value Ebitda 44.9639 | Price Sales 4.486 | Forward PE 41.3223 |
Overvalued
Today
Please note that Bloomage Biotechnology Co's price fluctuation is very steady at this time. Calculation of the real value of Bloomage Biotechnology Co is based on 3 months time horizon. Increasing Bloomage Biotechnology Co's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bloomage Biotechnology Co is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bloomage Stock. However, Bloomage Biotechnology Co's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 50.45 | Real 42.64 | Hype 50.45 | Naive 50.58 |
The real value of Bloomage Stock, also known as its intrinsic value, is the underlying worth of Bloomage Biotechnology Co Company, which is reflected in its stock price. It is based on Bloomage Biotechnology Co's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bloomage Biotechnology Co's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bloomage Biotechnology Corp helps investors to forecast how Bloomage stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bloomage Biotechnology Co more accurately as focusing exclusively on Bloomage Biotechnology Co's fundamentals will not take into account other important factors: Bloomage Biotechnology Co Cash |
|
Bloomage Biotechnology Co Total Value Analysis
Bloomage Biotechnology Corp is presently forecasted to have takeover price of 24.06 B with market capitalization of 24.09 B, debt of 153.13 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bloomage Biotechnology Co fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
24.06 B | 24.09 B | 153.13 M |
Bloomage Biotechnology Co Investor Information
About 60.0% of the company shares are owned by insiders or employees . The book value of Bloomage Biotechnology Co was presently reported as 14.67. The company last dividend was issued on the 8th of August 2024. Based on the analysis of Bloomage Biotechnology Co's profitability, liquidity, and operating efficiency, Bloomage Biotechnology Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 594.9 M | 804.6 M |
|
| |||||
| Operating Income | 730.2 M | 848.3 M |
|
|
Bloomage Biotechnology Co Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bloomage Biotechnology Co has an asset utilization ratio of 71.73 percent. This suggests that the Company is making USD0.72 for each dollar of assets. An increasing asset utilization means that Bloomage Biotechnology Corp is more efficient with each dollar of assets it utilizes for everyday operations.Bloomage Biotechnology Co Ownership Allocation
Bloomage Biotechnology Co holds a total of 481.68 Million outstanding shares. Bloomage Biotechnology Corp shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.1 percent of Bloomage Biotechnology Co outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bloomage Biotechnology Co Profitability Analysis
The company reported the revenue of 6.08 B. Net Income was 592.56 M with profit before overhead, payroll, taxes, and interest of 5.37 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bloomage Biotechnology Co's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bloomage Biotechnology Co and how it compares across the competition.
About Bloomage Biotechnology Co Valuation
The stock valuation mechanism determines Bloomage Biotechnology Co's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bloomage Biotechnology Co. We calculate exposure to Bloomage Biotechnology Co's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bloomage Biotechnology Co's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 5.1 B | 2.6 B |
Bloomage Biotechnology Co Quarterly Retained Earnings |
|
Complementary Tools for Bloomage Stock analysis
When running Bloomage Biotechnology Co's price analysis, check to measure Bloomage Biotechnology Co's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bloomage Biotechnology Co is operating at the current time. Most of Bloomage Biotechnology Co's value examination focuses on studying past and present price action to predict the probability of Bloomage Biotechnology Co's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bloomage Biotechnology Co's price. Additionally, you may evaluate how the addition of Bloomage Biotechnology Co to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |